Profhilo, developed by the renowned Swiss multinational pharmaceutical group
IBSA, has received CE (EU) approval.

It is a treatment based on a highly concentrated formulation of Hyaluronic Acid.

Its key ingredient is high-purity Hyaluronic Acid, produced using the patented NAHYCO™ technology, which uniquely combines high and low molecular weight molecules.

Its mechanism of action works upon application to the skin to stimulate fibroblasts, increasing the production of collagen and elastin; activate keratinocytes; and
maintain and promote the vitality of adipocytes. The product spreads evenly throughout the tissue.